RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...

The virus is a common respiratory illness that infects the lungs and airways. Most people experience mild symptoms, like the common cold. However, RSV can cause more severe symptoms in infants, older ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

The Illinois Department of Public Health says the state's overall respiratory illness level has moved from Moderate to High.

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

“We are still deep in winter virus season,” Berry said Monday. “We are continuing to see influenza activity in our community. After a couple of weeks of decline, we are seeing influenza on the rise.” ...

Right now, local hospitals are seeing more kids come in with bronchiolitis. The cases are mostly from RSV, which impacts the small airways in the lungs.

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Levels of respiratory illnesses such as COVID-19, influenza and RSV are on the rise. Here’s what you can do to keep yourself ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...